Biogen (BIIB)
(Delayed Data from NSDQ)
$199.36 USD
-2.08 (-1.03%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $199.26 -0.10 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Biogen Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 1,161.50 | 2,961.60 | 1,727.60 | 4,060.50 | 5,888.50 |
Depreciation/Amortization & Depletion | 526.30 | 518.40 | 1,117.00 | 457.20 | 680.60 |
Net Change from Assets/Liabilities | -648.70 | -890.30 | -145.50 | -187.20 | 199.30 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 508.10 | -1,205.40 | 940.80 | -100.70 | 310.20 |
Net Cash From Operating Activities | 1,547.20 | 1,384.30 | 3,639.90 | 4,229.80 | 7,078.60 |
Property & Equipment | -277.00 | 342.30 | -258.10 | -424.80 | -514.50 |
Acquisition/ Disposition of Subsidiaries | -6,138.00 | 990.30 | 28.10 | -1,006.50 | 623.70 |
Investments | 2,359.70 | 222.50 | -309.80 | 976.60 | 1,233.70 |
Other Investing Activities | -45.70 | 21.50 | -23.90 | -153.90 | -872.40 |
Net Cash from Investing Activities | -4,101.00 | 1,576.60 | -563.70 | -608.60 | 470.50 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | -751.90 | -1,800.70 | -6,683.70 | -5,868.30 |
Issuance (Repayment) of Debt | 187.30 | -1,002.20 | -170.00 | 1,467.40 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -38.00 | 6.80 | -115.50 | -56.40 | 7.90 |
Net Cash from Financing Activities | 149.30 | -1,747.30 | -2,086.20 | -5,272.70 | -5,860.40 |
Effect of Exchange Rate Changes | 35.10 | -55.70 | -59.80 | 69.00 | 0.40 |
Net Change In Cash & Equivalents | -2,369.40 | 1,157.90 | 930.20 | -1,582.50 | 1,689.10 |
Cash at Beginning of Period | 3,419.30 | 2,261.40 | 1,331.20 | 2,913.70 | 1,224.60 |
Cash at End of Period | 1,049.90 | 3,419.30 | 2,261.40 | 1,331.20 | 2,913.70 |
Diluted Net EPS | 7.97 | 20.87 | 10.40 | 24.80 | 31.42 |
Fiscal Year End for Biogen Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 977.00 | 393.40 | 1,161.50 | 912.60 | 980.90 |
Depreciation/Amortization & Depletion | 440.60 | 191.60 | 526.30 | 354.70 | 229.70 |
Net Change from Assets/Liabilities | -417.30 | -228.70 | -648.70 | -0.60 | -315.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 178.70 | 196.90 | 508.10 | 268.00 | 46.70 |
Net Cash From Operating Activities | 1,179.00 | 553.20 | 1,547.20 | 1,534.70 | 942.30 |
Property & Equipment | -79.40 | -45.90 | -277.00 | -211.80 | -137.60 |
Acquisition/ Disposition of Subsidiaries | 406.80 | 0.00 | -6,138.00 | -5,547.50 | 0.00 |
Investments | 57.50 | 55.60 | 2,359.70 | 2,346.30 | -2,334.90 |
Other Investing Activities | 15.60 | -75.70 | -45.70 | -35.70 | 766.00 |
Net Cash from Investing Activities | 400.50 | -66.00 | -4,101.00 | -3,448.70 | -1,706.50 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | -48.00 | -54.60 |
Issuance (Repayment) of Debt | -650.00 | -400.00 | 187.30 | 837.30 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -34.80 | -39.60 | -38.00 | 6.10 | 1.40 |
Net Cash from Financing Activities | -684.80 | -439.60 | 149.30 | 795.40 | -53.20 |
Effect of Exchange Rate Changes | -35.70 | -23.10 | 35.10 | -12.80 | 15.90 |
Net Change In Cash & Equivalents | 859.00 | 24.50 | -2,369.40 | -1,131.40 | -801.50 |
Cash at Beginning of Period | 1,049.90 | 1,049.90 | 3,419.30 | 3,419.30 | 3,419.30 |
Cash at End of Period | 1,908.90 | 1,074.40 | 1,049.90 | 2,287.90 | 2,617.80 |
Diluted Net EPS | 4.00 | 2.70 | 1.70 | -0.47 | 4.07 |